Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03503994Completed
Open-label trial of beclomethasone dipropionate in bronchopulmonary dysplasia (BPD) (4 arms), sponsored by Mount Sinai Hospital. Primary endpoints: Reduction in Fractional Oxygen Concentration of Inspired Gas > 75% at 1 week and Successful Extubation at 1 week. Started Jul 2001; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03503994.